Dapivirine

N/A

Report date: 2022/03/18 16:41:15
NME

Base Information

Drug NameDapivirine
Drug Alias NameDapivirine gel达匹韦林Dapivirine intravaginal ringDapivirine ring 004dapivirina +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsContraceptionAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUganda +[10] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesInternational Partnership For Microbicides IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsContraceptionAcquired Immunodeficiency Syndrome

Other Information

ATC CodeG01AX17
Related LinksWikipedia